A Preliminary Study of Prophylactic Fentanyl Pectin Nasal Spray (FPNS) for Exercise-Induced Breakthrough Dyspnea
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Fentanyl (Primary)
- Indications Dyspnoea
- Focus Therapeutic Use
- 27 Jun 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2019.
- 26 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 06 Jun 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.